Benzoimidazol-2-yl pyrimidines and pyrazines as modulators of the histamine H4 receptor

Benzoimidazol-2-yl pyrimidines and pyrazines, pharmaceutical compositions and methods for H4 receptor activity modulation and for the treatment of disease states, disorders, and conditions mediated by H4 receptor activity, including allergy, asthma, autoimmune diseases, and pruritis.

Saved in:
Bibliographic Details
Main Authors EDWARDS JAMES P, VENABLE JENNIFER D, PIPPEL DANIEL J, KINDRACHUK DAVID E, MAPES CHRISTOPHER M
Format Patent
LanguageEnglish
Published 21.03.2013
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
Online AccessGet full text

Cover

More Information
Summary:Benzoimidazol-2-yl pyrimidines and pyrazines, pharmaceutical compositions and methods for H4 receptor activity modulation and for the treatment of disease states, disorders, and conditions mediated by H4 receptor activity, including allergy, asthma, autoimmune diseases, and pruritis.
Bibliography:Application Number: US201213676595